NY A 10060
in committeeAuthorizes high schools to include opioid overdose prevention and non-intravenous opioid antagonist administration as part of required health education courses
New York · 2025-2026 Regular Session · lower
Quick answers
Did NY A 10060 pass?
Not yet. NY A 10060 is in committee as of 2026-04-01 and has not come to a final vote. Latest recorded action (2026-04-01): PRINT NUMBER 10060A
What is NY A 10060 about?
Authorizes high schools to include opioid overdose prevention and non-intravenous opioid antagonist administration as optional part of required health education courses; authorizes certain students to administer non-intravenous opioid antagonists.
Who sponsors NY A 10060?
Anna Kelles is the primary sponsor of NY A 10060, joined by 1 cosponsor.
Description
Authorizes high schools to include opioid overdose prevention and non-intravenous opioid antagonist administration as optional part of required health education courses; authorizes certain students to administer non-intravenous opioid antagonists.
- Introduced
- —
- Latest action
- 2026-04-01 — PRINT NUMBER 10060A
- Bill type
- bill
- Last updated
- —
Sponsors
- Anna Kellesprimary
- Phil Steckcosponsor
Committees
Not provided by source.
Action timeline
2026-01-30
REFERRED TO EDUCATION
referral-committee
2026-04-01
AMEND AND RECOMMIT TO EDUCATION
amendment-passage,referral-committee
2026-04-01
PRINT NUMBER 10060A
amendment-passage
Versions
Documents
Votes
Not provided by source.
Related bills
- Companion bill: S 10277
Official source
Attribution
Data from openstates_bulk_csv, retrieved 2026-07-24T05:28:30.722574Z
Inspect retained evidence for changes recorded after evidence tracking began:
Use this data
Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=NY&identifier=A 10060. See the API docs or the MCP server for AI assistants.
Known limitations
- Sponsor party and chamber affiliation are not yet captured by this API.
- Committee referrals are not yet captured.
See the methodology page for data sources and limitations.